| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |